European Code against Cancer 4th Edition: Alcohol drinking and cancer  by Scoccianti, Chiara et al.
Cancer Epidemiology 45 (2016) 181–188European Code against Cancer 4th Edition: Alcohol drinking and
cancer$
Chiara Scocciantia, Michele Cecchinib,1, Annie S. Andersonc, Franco Berrinod,
Marie-Christine Boutron-Ruaulte, Carolina Espinaa, Timothy J. Keyf, Michael Leitzmanng,
Teresa Norath, Hilary Powersi, Martin Wisemanl, Isabelle Romieua,*
a International Agency for Research on Cancer (IARC), 150 Cours Albert Thomas, 69372 Lyon Cedex 08, France
bHealth Policy Analyst OECD, 2 rue André Pascal, 75775 Paris Cedex 16, France
cCentre for Research into Cancer Prevention & Screening, Level 7, Mailbox 7, Ninewells Hospital & Medical School, Dundee, DD1 9SY, Scotland, United
Kingdom
d Fondazione IRCSS Istituto Nazionale dei Tumori, 1 via Venezian, 20133 Milan, Italy
e Institut Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif, France
fCancer Epidemiology Unit, Nufﬁeld Department of Population Health, University of Oxford, United Kingdom
gDepartment of Epidemiology and Preventive Medicine, University of Regensburg, 93042 Regensburg, Germany
hDepartment of Epidemiology and Biostatistics, School of Public Health Imperial College London, St Mary’s Campus, London W2 1PG, United Kingdom
iHuman Nutrition Unit, The Medical School, Beech Hill Road, Shefﬁeld S10 2RX, United Kingdom
lWorld Cancer Research Fund International, Second Floor, 22 Bedford Square, London WC1 B 3HH, United Kingdom
A R T I C L E I N F O
Article history:
Available online 2 November 2016
Keywords:
Alcohol drinking
Cancer
Ethanol
Acetaldehyde
Disease
Primary prevention
Europe
A B S T R A C T
Alcohol consumption is the third leading risk factor for disease and mortality in Europe. As evaluated by
the International Agency for Research on Cancer (IARC) Monographs, a causal relationship is established
for consumption of alcoholic beverages and cancers of the oral cavity, pharynx, larynx, oesophagus, liver,
colorectum and female breast, even at low and moderate alcohol intakes. The higher the amount of
alcohol consumed, the higher the risk of developing cancer. In Europe, an estimated 10% (95% CI: 7%–13%)
of all cancer cases in men and 3% (95% CI: 1%–5%) of all cancer cases in women are attributable to alcohol
consumption. Several biological mechanisms explain the carcinogenicity of alcohol; among them,
ethanol and its genotoxic metabolite, acetaldehyde, play a major role. Taking all this evidence into
account, a recommendation of the 4th edition of European Code against Cancer is: “ If you drink alcohol
of any type, limit your intake. Not drinking alcohol is better for cancer prevention.”
ã 2015 International Agency for Research on Cancer; Licensee Elsevier Ltd. This is an open access article
under the CC BY-NC-ND IGO 3.0 license (https://creativecommons.org/licenses/by-nc-nd/3.0/igo/).
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Alcohol consumption is linked to a large number of health
impairments, chronic diseases and deaths worldwide [1]. The
2012 Monograph of the International Agency for Research on
Cancer (IARC) strengthens the evidence on the carcinogenicity of
alcohol by tumour sites and by mechanisms of alcohol carcino-
genesis even for low and moderate alcohol intakes [2,3]. The IARC
Monographs reached the conclusion: “alcohol consumption is
carcinogenic to humans (Group 1); ethanol in alcoholic beverages
is carcinogenic to humans (Group 1); acetaldehyde associated with
the consumption of alcoholic beverages is carcinogenic to humans
(Group 1)” [2]. Overall, there is no consistent difference in cancer
risk between different types of alcoholic beverages [4–6]. While
the mechanisms of alcohol carcinogenesis are not fully understood,
the direct carcinogenicity of ethanol and its metabolites, the
interplay with folate metabolism and the oestrogen pathway have
been suggested, all of which would be further modulated by use
patterns and genetic and environmental factors [2,3].Box 1. European Code Against Cancer.
EUROPEAN CODE AGAINST CANCER
12 ways to reduce your cancer risk
1. Do not smoke. Do not use any form of tobacco.
2. Make your home smoke free. Support smoke-free
policies in your workplace.
3. Take action to be a healthy body weight.
4. Be physically active in everyday life. Limit the time you
spend sitting.
5. Have a healthy diet:
 Eat plenty of whole grains, pulses, vegetables and
fruits.
 Limit high-calorie foods (foods high in sugar or fat)
and avoid sugary drinks.
 Avoid processed meat; limit red meat and foods high
in salt.
6. If you drink alcohol of any type, limit your intake. Not
drinking alcohol is better for cancer prevention.
7. Avoid too much sun, especially for children. Use sun
protection. Do not use sunbeds.
8. In the workplace, protect yourself against cancer-
causing substances by following health and safety
instructions.
9. Find out if you are exposed to radiation from naturally
high radon levels in your home. Take action to reduce
high radon levels.
10. For women:
 Breastfeeding reduces the mother’s cancer risk. If you
can, breastfeed your baby.
 Hormone replacement therapy (HRT) increases the
risk of certain cancers. Limit use of HRT.
11. Ensure your children take part in vaccination pro-
grammes for:
 Hepatitis B (for newborns)
 Human papillomavirus (HPV) (for girls).
12. Take part in organized cancer screening programmes
for:
 Bowel cancer (men and women)
 Breast cancer (women)
 Cervical cancer (women).
The European Code Against Cancer focuses on actions that
individual citizens can take to help prevent cancer. Success-
ful cancer prevention requires these individual actions to be
supported by governmental policies and actions.Europe is the highest alcohol-consuming region in the world,
with an average consumption of more than twice the global
average, a high prevalence of hazardous drinkers and an average
alcohol-attributable cancer burden which by far exceeds the
global average as well [1]. Taken together, the 4th edition of the
European Code Against Cancer (Box 1) [7] advocates action-
oriented recommendations for the general public. The Code
recommends decreasing or cutting alcohol consumption in order
to both prevent several types of cancer and to improve overall
health.
1.1. European alcohol consumption among adult and young
generations
Per capita alcohol consumption has been falling in the European
Union (EU) as a whole over the past three decades, while remaining
particularly high compared to the global average consumption. The
most recent data from the Organisation for Economic Co-operation
and Development show that individuals aged 15 years drink on
average 9.4 L of pure alcohol per year [8]. Consumption tends to be
higher in the Central-Eastern and Eastern countries as, for
example, Estonia, Lithuania and Austria, all of which have an
average consumption higher than 12 L per capita. At the other end
of the spectrum, Mediterranean countries (e.g. Italy, Malta and
Greece) and Nordic Countries (e.g. Norway, Sweden and Iceland)
have relatively lower levels of consumption, in the region of 6–8 L
of pure alcohol per adult person (Fig. 1). Gender, age and socio-
economic status [9] are key factors in determining levels of alcohol
consumption. Men are more likely to consume alcohol than
women, and to drink more when they do [10], particularly in
Central, Western and Northern EU countries. Compared to older
adults, young and middle-aged people tend to drink higher
volumes of alcohol [11]. Women with higher level of education
tend to drink more alcohol while the opposite is generally true for
men [10]. Hazardous drinking behaviours, such as binge drinking
(i.e., the consumption of 60 g of pure alcohol on the same
occasion and at least one day in the last month), have been
increasing over the past 20 years [13], especially in Germany and
Ireland and among younger generations [14–17]. The volume of
alcohol consumed on a single occasion is important for many acute
consequences of drinking such as alcohol poisoning, injury and
violence. The prevalence of binge drinkers doubled in France and
has increased by about 30% in Germany between 2002 and 2008
[13]. Repeated drunkenness among 15-years olds was reported by
36% of girls and 40% of boys in 2010 [8].
1.2. Effect of alcohol drinking on coronary heart disease
The evidence of a reduced risk of coronary heart disease at
light to moderate alcohol consumption is important to consider.
Several studies suggest a lower risk of both nonfatal myocardial
infarction and fatal heart disease, likely conﬁned to middle-aged
or older individuals, when consuming one drink every second
day compared to none [18–20]. However, controversy remains
about whether this relationship is truly causal. Recent studies
argue that alcohol consumption may increase the risk of heart
disease even at low intakes and that the observed protective
associations could be due to reverse causation and residual
confounding [21,22].
2. Association with cancer
2.1. Cancer types associated with alcohol drinking
As evaluated by the IARC Monographs, alcohol consumption
causes cancers of the oral cavity, pharynx, larynx, oesophagus,
Fig. 1. Average European alcohol consumption in adults.
Average alcohol consumption in litres/capita/year among populations aged 15 years and over (years 2012 and 1980).
Source: Calculations provided by the OECD based on “Health at a glance: Europe 2014. OECD Publishing, 2014” [8].
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female breast [2]. The level of evidence from main meta-analyses
at both light and heavy drinking is indicated in Table 1. The
relationship between alcohol consumption and the risk of cancer is
shown in Fig. 2. More research is needed to determine if and to what
extent these relative risk functions differ by cancer incidence and
mortality. For the majority of the above cited cancer sites the
associations are linear, except for those cancers more strongly
related to alcohol consumption such as the upper digestive tract
cancers.
Also an association has been observed between alcohol
consumption and cancer of the pancreas [2]. For cancer of the
kidney, Hodgkin and non-Hodgkin lymphomas there is evidence
suggesting lack of carcinogenicity [2]. It is not possible to draw any
conclusions for cancers of the prostate, bladder, lung, stomach,Table 1
Risk of cancer at light or heavy alcohol drinking.
Cancer ICD-10 code Referen
Oral cavity C00-C06 Turati 2
Pharynx C09-C14 
Oral cavity and Pharynx C00-C14 Turati 2
Larynx C32 Islami 2
Oesophagus and gastric cardia C15-C16 Tramace
Oesophagus C15 Islami 2
Colorectal C18-C21 Fedirko 
Liver C22 Corrao 2
Female breast C50 Bagnard
Corrao 2
ICD-10: International Classiﬁcation of Diseases, 10th Revision [87].
a Summary relative risk and 95% conﬁdence interval.
b Light drinker:  1drink (or 12.5 g) per day; Heavy drinker: 4 drinks (or 50 g) per 
c Light drinker: 1–2 drinks (or  25 g) per day; Heavy drinker: 4 drinks (or 50 g) peendometrium, ovary, cervix, vulva and vagina, testis, brain, thyroid,
skin, leukaemia and multiple myelomia [23].
Overall, the risk of cancer in men who consume less than two
alcoholic drinks per day and in women who consume less than one
alcoholic drink per day is 6% lower than that in people with higher
alcohol consumptions. In Europe, it has been estimated that about
10% (95% CI: 7%–13%) of all cancer cases in men and 3% (95% CI: 1%–
5%) of all cancer cases in women are attributable to alcohol
consumption [24]. In both genders, the alcohol-attributable fraction
ishigh for upperaero-digestive tract (25%–44%), liver (18%–33%), and
colorectal (4%–17%) cancers, and in women for breast cancer (about
5%), with variation across EU countries related to different levels of
exposure to alcohol [24]. Drinking patterns play an important role in
modulating the relationship between alcohol and cancer risk, as the
strongest associations are observed for heavy drinking, in particularce RR (95% CI)a
Light drinkersb
RR (95% CI)a
Heavy drinkersb
010 [88] 1.17 (1.01–1.35) 4.64 (3.78–5.70)
1.23 (0.87–1.73) 6.62 (4.72–9.29)
013c [30] 1.36 (1.20–1.54) 5.40 (4.49–6.50)
010c [28] 0.88 (0.71–1.08) 2.62 (2.13–3.23)
re 2012 [89] 0.86 (0.75–0.99) 1.16 (0.92–1.46)
011 [29] 1.32 (0.90–1.60) 3.35 (2.35–4.78)
2011 [40] 1.00 (0.95–1.05) 1.52 (1.27–1.81)
004c [41] 1.19 (1.12–1.27) 1.40 (1.25–1.56)
i 2013 [44] 1.05 (1.02–1.08)
004c [41] 1.25 (1.20–1.29) 1.55 (1.44–1.67)
day.
r day.
Fig. 2. Relationship between average daily alcohol consumption and relative risk of cancer.
Plots of the relative risk functions for all cancers causally associated with alcohol consumption. Relative risks of cancer are strongest for the upper digestive tract (scale 0.0-
10.0), followed by female breast (scale 0.0-4.0) and lower digestive tract (scale 0.0-2.5).
Source: G. Corrao, V. Bagnardi, A. Zambon, C. La Vecchia A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev. Med. 2004, 38:613–619. http://dx.doi.org/
10.1016/j.ypmed.2003.11.027 PMID:15066364 [41].
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beneﬁcial effect on reducing the risk of cancer.
2.1.1. Neoplasms of the upper digestive tract
Results from cohort studies and recent meta-analyses provide
convincing evidence that the consumption of alcoholic beverages
increases the risk of neoplasms of the upper digestive and
respiratory tract (UADT: oral cavity, pharynx, larynx and squamous
cell carcinoma of the oesophagus) even in the absence of smoking.
Signiﬁcant dose-response relationships are found with different
metrics of exposure to alcohol, such as level, frequency [25] and
duration [26] of consumption and for moderate intake in women
[4,27,28]. Among non-smokers, reported RRs for oesophageal
squamous cell carcinoma and laryngeal cancer range from 0.74
(95% CI: 0.47–1.16) for light intakes, to 3.09 (95% CI: 1.75–5.46) for
high intakes [27–29]. Risks for oropharyngeal cancer are as high as
5.40 (95% CI: 4.49–6.50) [30]. The combined exposure to alcohol
consumption and tobacco smoking results in a supra-multiplica-
tive synergistic effect which enhances the risk of these neoplasms
up to 14-fold, among heavy-smokers and heavy drinkers (4 or more
drinks/day) [31,32] (Fig. 3).
There is evidence that risk of UADT cancer decreases with time
since drinking cessation, without however ever falling to that of
lifetime abstainers. A recent meta-analysis reports an average 2%
decreased risk of pharyngeal and laryngeal cancers per year of
cessation [33]. A trend for decreased risk is suggested for laryngeal,
oropharyngeal and oesophageal cancers, among former drinkers.
After at least 6 years of drinking cessation, odds ratios decreased to
1.24 (95% CI: 0.68–2.47) [34],1.74 (95% CI: 0.77–3.92) [35], and 0.85
(95% CI: 0.78–0.92) [36,37], for laryngeal, oropharyngeal and
oesophageal cancers, respectively.
2.1.2. Neoplasms of the lower digestive tract
Results from cohort studies and recent meta-analyses provide
overall evidence of a linear dose-response relationship between
average alcohol consumption and colorectal and liver cancers.
Summary effect estimates for colorectal cancer are about 11%
(RR = 1.11; 95% CI: 0.90–1.38) at one drink/day (corresponding to
10-12 g of ethanol) and 40% (RR = 1.41; 95% CI: 1.16–1.72) at more
than 4–5 drinks/day [38]. Risk is higher for drinkers with a family
history of colorectal cancer (RR = 2.80; 95% CI: 2.00–3.91, at 30 g/Fig. 3. Estimated RR for the interaction between tobacco smoking and alcohol
drinking on cancers of the upper digestive and respiratory tract (reference category,
risk = 1).
Combined exposure to alcohol drinking and tobacco smoking increases the risk of
upper digestive and respiratory tract neoplasms in a supra-multiplicative manner.
Source: P. Boyle, P. Autier, H. Bartelink, et al. European Code Against Cancer and
scientiﬁc justiﬁcation: third version (2003) Annals of Oncology 2003, 14: 973–1005,
by permission of Oxford University Press [7,86].d compared with non-drinkers with no family history) [39].
Overall, the estimated RRs at 2–3 drinks per day compared with
non-drinkers are 1.23 (95% CI: 1.13–1.35) and 1.15, (95% CI:
1.06–1.24), respectively for rectal and colon cancer, and slightly
higher in men (RR = 1.24; 95% CI: 1.13–1.37) than in women
(RR = 1.08; 95% CI: 1.03–1.13) [40]. In both genders combined, dose-
response analyses show RRs of 1.07 (95% CI: 1.04–1.10), 1.38 (95%
CI: 1.28–1.50) and 1.82 (95% CI: 1.41–2.35) at 10, 50 and 100 g/day
of alcohol consumption, respectively [40].
Chronic liver cirrhosis, associated with prolonged heavy
(60–80 g/day) alcohol consumption, usually develops well ahead
of hepatocellular carcinoma. Thus, associations of alcohol con-
sumption with hepatocellular carcinoma are generally found at
high intakes with signiﬁcant increased risks of about 30–40% at
consumption levels greater than 40 g/day [41–43]. However,
increased risks at low to moderate alcohol consumption are also
reported [4,44,45] and overall the dose-response relationship
between alcohol consumption and the risk of liver cancer is linear.
2.1.3. Neoplasms of the female breast
A positive association between alcoholic beverages consump-
tion and breast cancer risk is supported by more than 100 epide-
miological studies [2]. The risk per 10 g/day of ethanol is increased
by 8% for post-menopausal breast cancer, 9% for pre-menopausal
breast cancer, and 10% for all-age breast cancer [46]. While studies
on binge drinking and cancer risk are still sparse and a
standardized measure of exposure is lacking, the available
evidence shows that risk is increased between 33% (95% CI:
1.11–1.59, for monthly binge drinking) [47] and 55% (95%: CI 1.07–
2.26, for weekly binge drinking) [48].
Women may be more susceptible to alcohol carcinogenesis
when exposed at young age, since alcohol may act early in the
carcinogenic process upon the expression of oestrogen receptors
which regulate the development of the mammary gland. This
susceptibility window of exposure to alcohol consumption may
be further deﬁned by hormonal status or ﬁrst full-term pregnancy
[49]. However, at present few studies have investigated whether
and to what extent the age at exposure increases cancer risk and
the evidence is generally limited. In the Nurses' Health Study
(NHS) II, alcohol consumption before ﬁrst pregnancy was
consistently associated with an increased risk of proliferative
benign breast disease, which may lead to invasive breast cancer
later in life [50]. In a recent analysis of the EPIC study, breast
cancer risk was stronger among women who started drinking
alcohol prior to ﬁrst full-time pregnancy suggesting that timing of
exposure to alcohol drinking may affect the risk [51]. Alcohol
consumption in both early and late adulthood appears to increase
the risk of breast cancer. A NHS prospective analysis also reported
similar breast cancer risks for categories of age at alcohol
exposure of 18–40 years and >40 years (RRs = 1.21, 95% CI: 0.88–
1.67 and 1.18, 95% CI: 1.03–1.34, respectively, for a daily intake
20 g compared to none) [47]. Similar results were also observed
in a large Danish cohort of post-menopausal women, suggesting
that lifetime alcohol consumption is an important factor for
breast cancer risk [52].
2.2. Possible biological mechanisms
Alcoholic beverages mainly comprise ethanol and water and, in
minor percentage, other volatile and non-volatile compounds.
Ethanol is the most important carcinogen, moreover, ethanol’s
metabolism activates various pro-carcinogens present, as well as
inhaled or ingested, in alcoholic beverages. Regarding breast
cancer, ethanol most likely acts as both a weak cumulative
carcinogen and a tumour promoter of pre-existing breast cancer
cells [53]. For cancers of the oral cavity, pharynx, larynx and
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drinkers and smokers is explained by the synergistic effect of
carcinogens contained in tobacco smoke and in alcoholic
beverages which leads to mucosal hyperproliferation [54–61].
The risk of digestive tract cancers is modulated by variants of
the ethanol metabolising enzymes, the alcohol and acetaldehyde
dehydrogenases (ADH and ALDH). The ADH1 B 47Arg allele is
strongly associated with increased UADT cancer risk (RR = 3.47;
95% CI: 2.76–4.36 for the Arg/Arg genotype compared to the His/
His genotype) [58]. The fast metabolising ADH1C*1 variant, which
is more frequent in Caucasians [59], may increase risk of head and
neck cancer [60,61]. The ALDH2 Lys487 allele promotes acetalde-
hyde accumulation and is associated with higher risk of
oesophageal cancer [2].
Ethanol also disrupts folate metabolism regulated by methyl-
enetetrahydrofolate reductase (MTHFR) [62]; an individual’s
genotype for the C677T MTHFR variant modulates the effect of
alcohol consumption on cancer risk. The CC or CT variants may
increase colorectal cancer risk among alcohol drinkers (RR = 1.87;
95% CI: 1.29–2.71) [63]. The TT variant decreases MTHFR activity by
70% and appears to modulate risks of breast cancer, in association
with low folate intake [64,65], and of oral cancer [66], at daily
consumption of 2 drinks.
An important mechanism for breast cancer development might
be an alcohol-related increase in androgen and oestrogen levels
[67]. Most studies observe an overall stronger association with the
most common oestrogen receptor positive (ER+) and/or proges-
terone receptor positive (PR+) compared with ER- and/or PR-
breast tumours, for the highest versus the lowest alcohol
consumption group [67–70]. However, a recent meta-analysis
showed that for each additional drink, breast cancer risk increases
by 12% among ER+, by 11% among ER+ PR+, by 15% among ER+ PR,
and by 7% for all ER- tumours, and no association was apparent
with ER-/PR- or ER/PR+ tumours when considered separately,
thus suggesting that the impact of ethanol can only be explained by
the oestrogen-dependent pathway [71]. In the EPIC study,
increased breast cancer risk was observed for ER+/PR+, ER-/PR-
and ER-/PR-HER- supporting the concept that non-hormonal
pathways such as DNA damage might be involved in the incidence
of receptor negative tumours [51].
Other ethanol-mediated toxic effects associated with cancer
development are cirrhosis of the liver and gastro-oesophageal
reﬂux disease, which leads to hyperproliferation of the oesopha-
geal mucosa. Also, ethanol-associated immune suppression may
facilitate tumour cell spread [62].
3. Justiﬁcation for recommendation
The consumption of alcoholic beverages is causally associated
with cancers of the oral cavity, pharynx, larynx, oesophagus, liver,
colorectum and female breast. For these organ sites, risk
estimates of alcohol-related cancer incidence and mortality
emphasize a dose-dependent relationship that does not vary
by beverage type and does not show a threshold of intake, with an
adverse effect observed even at consumption of less than
1 alcoholic drink per day [12,72]. Ethanol carcinogenesis may
not uniformly target tissues and may depend on drinking patterns
and timing of exposure, as based on observed differences in
cancer risk across all organ sites.
3.1. Alcohol-attributable burden of disease
In Europe, alcohol is the third leading risk factor for disease and
mortality after tobacco and high blood pressure [73]. In addition to
cancer, alcohol consumption is causally associated with about
60 types of diseases, including heart disease, stroke and vasculardiseases, as well as liver cirrhosis, birth defects and intellectual
impairments. Alcohol also contributes to death and disability
through accidents and injuries, assault, violence, homicide and
suicide. Alcohol is a psychoactive substance with dependence-
producing properties. Disease burden is mostly related with
alcohol’s capacity to produce dependence and with acute
intoxication, which together represent 44.5% of the alcohol-
related morbidity in men [1].
In the EU in 2004, almost 95,000 men and more than 25,000
women, aged 15–64, died prematurely of alcohol-attributable
causes. This means that 1 in 7 male and 1 in 13 female premature
deaths in this age category were caused by alcohol [73]. In men in
2004, approximately two-ﬁfths of deaths were due to liver
cirrhosis, one third to injuries, compared to one in ﬁve (15.9%)
for cancer. In women, approximately more than two thirds of
alcohol-attributable deaths arose from liver cirrhosis and from
cancer (30.7%; the largest proportion of which, 21%, concerns
breast cancer), with cardiovascular disease other than ischaemic
heart disease as a distant third cause.
Almost 90% of the burden of disease attributable to alcohol is
caused by heavy drinking, both regular and irregular. This has
important implications for prevention and alcohol policy: any
measure which wants to successfully reduce alcohol-attributable
harm has to cut down regular and irregular heavy drinking
occasions.
3.2. Public policies on alcohol taxation as measures of prevention
Negative health effects and social harm caused by detri-
mental alcohol consumption can be reduced though effective
prevention strategies. In 1979, the World Health Assembly
called upon World Health Organization (WHO) member states
to develop and adopt appropriate legislation and measures to
tackle alcohol misuse [74]. In 2010, a global strategy on the
harmful use of alcohol was endorsed, to support target areas for
national actions including health sector response, drink-driving
policies, limitation of the availability of alcohol, and action on
marketing and pricing policies [75]. Based on four key criteria
(namely effectiveness, affordability, efﬁciency and acceptability/
feasibility), WHO has more recently identiﬁed restricted access
to retailed alcohol, limitation of alcohol advertising and taxes
on alcohol as the best performing interventions to tackle
harmful alcohol use [76].
Alcohol prices, and consequently affordability, are a strong
determinant of alcohol consumption and can be altered by using
taxes or direct price controls, including minimum price policies
[77]. Overall, and despite inhomogeneous public policies on
alcohol taxation across the EU, countries with more strict alcohol
policies and decreased affordability generally report lower levels
of alcohol consumption [75]. On average, a 10% increase in the
price of alcohol is correlated to a 4.4% decrease in consumption,
with some variability depending on the type of alcoholic beverage
[78]. Time-series analyses in Canada (British Columbia) showed
that a 10% increase in the minimum price for alcohol reduces
consumption of spirits by 6.8%, of wine by 8.9%, of alcopops
(ﬂavoured, often sweet, alcoholic beverages) by 13.9% and of beer
by 1.5% [79]. In spite of the above evidence, the real price of
alcoholic beverages is decreasing and an approximate 50%
increase in affordability was recorded between 1996 and
2004 in several European countries [80].
The most common approach in the EU is based on a
combination of excise duty and value added taxes, which should
account for potential effects of the type of beverage consumed. As
an example, the introduction of a tax on alcopops in Germany
simply shifted consumption from spirit-based to beer-based
C. Scoccianti et al. / Cancer Epidemiology 45 (2016) 181–188 187beverages [81]. Observational studies suggest that the effects of
taxation would be larger for moderate than heavy drinkers [82],
women [83] and young consumers [84].
Taking all these issues into account, the European Code Against
Cancer has developed the following recommendation:
“If you drink alcohol of any type, limit your intake. Not drinking
alcohol is better for cancer prevention.”
4. Conclusion
Worldwide, alcohol use is the second leading risk factor in
terms of morbidity, and it accounts for a signiﬁcant number of
deaths, particularly in high-income countries. In Europe, it has
been estimated that about 3%-10% of all cancer cases are
attributable to alcohol consumption [24]. There is strong evidence
that people can reduce their risk of cancer by limiting or cutting
their consumption of alcoholic drinks. Overall, in European
populations the risk of cancer in men who consume less than
two alcoholic drinks (less than 20 g of pure alcohol) per day and in
women who consume less than one alcoholic drink (less than 10 g
of pure alcohol) per day is 6% lower (hazard ratio = 0.94; 95% CI:
0.90–0.96) than that in people with higher alcohol intakes [85]. On
average, reducing the consumption from four-or-more to one-or-
less alcoholic drinks per day may reduce the risk of liver cancer by
21% [41], the risk of colorectal cancer by 31% [40], and the risk of
female breast cancer by 30% [41]. WHO have stated clearly that
increasing price, reducing availability and banning advertising are
the most effective policy measures that should be implemented at
the European level in order to decrease the alcohol-related burden
of disease.
The resulting recommendation of the 4th edition of the
European Code Against Cancer targeted to individuals is to limit
or cut the consumption of alcoholic beverages.
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